Guoli Li

机构：Hunan Normal University, Sir Run Run Shaw Hospital · ORCID：0000-0003-0450-2529

发表论文 140 篇 · 总被引 3499 次 · h-index 28

代表论文

• Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 56)
• Serotonin signaling to regulate energy metabolism: a gut microbiota perspective (2024 · Life Metabolism · 被引 29)
• Aptamer-functionalized nucleic acid nanotechnology for biosensing, bioimaging and cancer therapy (2024 · Nanoscale · 被引 19)
• Global burden and trends of high BMI-attributable chronic kidney disease: a comprehensive analysis from 1990 to 2021 and projections to 2035 (2025 · Frontiers in Nutrition · 被引 9)
• Butyrate Prevents Obesity Accompanied by HDAC9-Mediated Browning of White Adipose Tissue (2025 · Biomedicines · 被引 7)
• Impact of body composition, grip strength, and physical performance on clinical outcomes for locally advanced gastric cancer during neoadjuvant chemotherapy: A prospective cohort study (2024 · Nutrition · 被引 5)